Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SIR-2501 by Sironax for Neuropathy: Likelihood of Approval
SIR-2501 is under clinical development by Sironax and currently in Phase I for Neuropathy. According to GlobalData, Phase I drugs...
Data Insights
SIR-2501 by Sironax for Neurodegenerative Diseases: Likelihood of Approval
SIR-2501 is under clinical development by Sironax and currently in Phase I for Neurodegenerative Diseases. According to GlobalData, Phase I...